Catequentinib - CISMeF

Preferred Label : Catequentinib;

NCIt synonyms : Cyclopropanamine, 1-(((4-((4-Fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-quinolinyl)oxy)methyl)-; Anlotinib;

NCIt definition : A receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic and anti-angiogenic activities. Upon administration, catequentinib targets multiple RTKs, including vascular endothelial growth factor receptor type 2 (VEGFR2) and type 3 (VEGFR3). This agent may both inhibit angiogenesis and halt tumor cell growth.;

UNII : GKF8S4C432;

InChIKey : KSMZEXLVHXZPEF-UHFFFAOYSA-N;

CAS number : 1058156-90-3;

Molecule name : AL 3818; AL-3818;

NCI Metathesaurus CUI : CL526447;

Codes from synonyms : 121127;

Details

Origin ID

C138997;

UMLS CUI

C4519250;

Currated CISMeF NLP mapping
- anlotinib [MeSH Supplementary Concept]
- anlotinib [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- anlotinib [MeSH Supplementary Concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- HemOnc Agent Terminology [NCIt concept]
has_salt_form
- Catequentinib Hydrochloride [NCIt concept]
is_free_acid_or_base_form_of
- Catequentinib Hydrochloride [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients